1. Home
  2. Companies
  3. IBX
  4. Material Events

Imagion Biosystems (ASX:IBX) — Material Events

ASX:IBX · 11 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 8 articles Notable 3 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
8
Imagion Biosystems Secures $3.75m to Kickstart HER2 Breast Cancer TrialMedium
Imagion Biosystems raises $3.75m to fund Phase 1b/2 HER2 breast cancer clinical trial
25 June 2026 ·Capital Raising ·85
Imagion Biosystems Advances HER2 Breast Cancer Trial with FDA IND Submission on TrackMedium
Imagion Biosystems on track for FDA IND submission and Phase 2 HER2 breast cancer trial in early 2026
1 Dec 2025 ·Company Announcement ·85
Imagion Biosystems Advances HER2 Imaging Agent with FDA Backing and $3.5M RaiseHigh
Imagion Biosystems Advances HER2 Imaging Agent with FDA Support, $3.5M Capital Raise, and IND Filing Planned for Q4 2025
21 Oct 2025 ·Quarterly Activities and Appendix 4C ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.